HDAC9 and hepatocellular carcinoma: Gut microbiota‐derived acetate can modulate type 3 innate lymphoid cell function by inhibiting HDAC activity and boost anti‐PD1 efficacy in hepatocellular carcinoma (HCC) mouse models.20